NO981052L - Peptidderivater - Google Patents

Peptidderivater

Info

Publication number
NO981052L
NO981052L NO981052A NO981052A NO981052L NO 981052 L NO981052 L NO 981052L NO 981052 A NO981052 A NO 981052A NO 981052 A NO981052 A NO 981052A NO 981052 L NO981052 L NO 981052L
Authority
NO
Norway
Prior art keywords
residue
alanine
peptide
substituted
pro
Prior art date
Application number
NO981052A
Other languages
English (en)
Norwegian (no)
Other versions
NO981052D0 (no
Inventor
Shinobu Sakurada
Toru Okayama
Eriko Nukui
Kazuya Hongo
Tadashi Ogawa
Tomoko Hongo
Satoko Takeshima
Nobuhiro Take
Masaharu Nakano
Original Assignee
Daiichi Seiyaku Co
Fuji Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co, Fuji Chemical Ind Ltd filed Critical Daiichi Seiyaku Co
Publication of NO981052D0 publication Critical patent/NO981052D0/no
Publication of NO981052L publication Critical patent/NO981052L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO981052A 1995-09-11 1998-03-10 Peptidderivater NO981052L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP23216295 1995-09-11
JP10008196 1996-04-22
PCT/JP1996/002573 WO1997010262A1 (fr) 1995-09-11 1996-09-10 Derives peptidiques

Publications (2)

Publication Number Publication Date
NO981052D0 NO981052D0 (no) 1998-03-10
NO981052L true NO981052L (no) 1998-05-11

Family

ID=26441170

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981052A NO981052L (no) 1995-09-11 1998-03-10 Peptidderivater

Country Status (8)

Country Link
EP (1) EP0850950A4 (de)
KR (1) KR19990044554A (de)
CN (1) CN1202174A (de)
AU (1) AU718320B2 (de)
CA (1) CA2231220A1 (de)
EA (1) EA001001B1 (de)
NO (1) NO981052L (de)
WO (1) WO1997010262A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999033864A1 (fr) * 1997-12-26 1999-07-08 Daiichi Pharmaceutical Co., Ltd. Derives peptidiques
WO2000012539A1 (fr) * 1998-08-31 2000-03-09 Fuji Chemical Industries, Ltd. Composes de peptides
US6593466B1 (en) 1999-07-07 2003-07-15 Isis Pharmaceuticals, Inc. Guanidinium functionalized nucleotides and precursors thereof
EP1968635B1 (de) * 2005-12-14 2014-09-17 Ambrx, Inc. Zusammensetzungen und Verfahren mit und Verwendung von nicht-natürlichen Aminosäuren und Polypeptiden
WO2007145208A1 (ja) 2006-06-12 2007-12-21 Vexon, Inc. ペプチド誘導体
WO2007144979A1 (ja) * 2006-06-12 2007-12-21 Vexon, Inc. ペプチド誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2166139B (en) * 1984-10-25 1988-06-22 Erba Farmitalia Biologically active penta-and heptapeptides
CZ168194A3 (en) * 1992-11-12 1994-12-15 Biomeasure Opioid peptides
DE69511259T2 (de) * 1994-03-11 2000-01-05 Daiichi Seiyaku Co N-amidino- dermorphin-derivat

Also Published As

Publication number Publication date
EA199800289A1 (ru) 1998-08-27
NO981052D0 (no) 1998-03-10
CA2231220A1 (en) 1997-03-20
AU6890696A (en) 1997-04-01
AU718320B2 (en) 2000-04-13
KR19990044554A (ko) 1999-06-25
EA001001B1 (ru) 2000-08-28
CN1202174A (zh) 1998-12-16
WO1997010262A1 (fr) 1997-03-20
EP0850950A1 (de) 1998-07-01
EP0850950A4 (de) 1999-05-19

Similar Documents

Publication Publication Date Title
RU94036758A (ru) Применение 2-фенил-3-ароилбензотиофенов для лечения пери-менопаузного синдрома
ATE224374T1 (de) 1,2-substituierte imidazolylverbindungen zur behandlung von entzündungen
TR200200205T2 (tr) MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi
ATE148130T1 (de) Typ-iv-dipeptidyl-aminopeptidase-inhibitoren
EP1125932A3 (de) Substituierte Thiazole zur Behandlung von Entzündungen
TR200800474T2 (tr) Florfenikole aracı maddelerin hazırlanmasına ilişkin işlem.
IL126610A0 (en) N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3- one derivatives as factor xa inhibitors
LU91145I2 (fr) FIROCOXIB facultativement sous forme d'un sel pharmaceutiquement acceptable (PREVICOX).
ATE260658T1 (de) Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen
ATE295346T1 (de) N-(aryl/heteroarylacetyl)aminosäureester, diese enthaltende pharmazeutische zusammensetzungen und methoden zur inhibierung der beta- amyloidfreisetzung und/oder deren synthese unter verwendung dieser verbindungen
EP1486207A3 (de) Sulfonierte Aminosäurederivate und diese enthaltende Metalloproteinaseinhibitoren
RU94017851A (ru) Ингибиторы протеолитических ферментов на основе производных сахарина, фармацевтическая композиция для лечения дегеративных заболеваний
WO1998022493A3 (en) N-(ARYL/HETEROARYL) AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS
YU49094B (sh) Postupak za dobijanje sinergističke terapeutske kompozicije
CA2296036A1 (en) Dolastatin 15 derivatives
DK0831100T3 (da) Nye peptidderivater
AP9701041A0 (en) Pyridylpyrrole compounds.
DK0930883T3 (da) Neurotrofinantagonister til behandling af epilepsi, Alzheimers sygdom og smerte
MX9604367A (es) Hidroxipiridinonas novedosas.
CA2354774A1 (en) Farnesyl protein transferase inhibitors
MX9709398A (es) N-aril-1,2,4-triazolin-5-onas.
EP0296581A3 (de) Aminosäure-1,2-Diketo-Derivate als Renin-Hemmungsstoffe
DE69617005T2 (de) 2-amino-benzoxazinone zur behandlung von viralen infektionen
BG101138A (en) The use of glyceryltriacetate for the treatment of onychomycosis
NO981052L (no) Peptidderivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application